S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover

Evolent Health (EVH) Stock Price, News & Analysis

$34.07
+4.30 (+14.44%)
(As of 02/23/2024 ET)
Today's Range
$31.30
$34.07
50-Day Range
$29.41
$34.07
52-Week Range
$23.33
$36.70
Volume
3.80 million shs
Average Volume
922,362 shs
Market Capitalization
$3.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.38

Evolent Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
21.4% Upside
$41.38 Price Target
Short Interest
Bearish
9.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.61mentions of Evolent Health in the last 14 days
Based on 24 Articles This Week
Insider Trading
Selling Shares
$3.74 M Sold Last Quarter
Proj. Earnings Growth
144.64%
From $0.56 to $1.37 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.56 out of 5 stars

Computer And Technology Sector

345th out of 585 stocks

Management Services Industry

5th out of 5 stocks


EVH stock logo

About Evolent Health Stock (NYSE:EVH)

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

EVH Stock Price History

EVH Stock News Headlines

Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich
For the first time ever, multimillionaire investor Karim Rahemtulla is exposing the most guarded secret of the ultra-rich. He's revealing how America's top 0.1% collect huge, passive income... day after day after day. It's how Warren Buffett made TENS OF BILLIONS for his Berkshire Hathaway fund. Best of all... you don't have to be rich to benefit from this method too!
Evolent Health (NYSE:EVH) Shares Gap Up Following Analyst Upgrade
Analyst Scoreboard: 4 Ratings For Evolent Health
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich
For the first time ever, multimillionaire investor Karim Rahemtulla is exposing the most guarded secret of the ultra-rich. He's revealing how America's top 0.1% collect huge, passive income... day after day after day. It's how Warren Buffett made TENS OF BILLIONS for his Berkshire Hathaway fund. Best of all... you don't have to be rich to benefit from this method too!
Barclays Reaffirms Their Buy Rating on Evolent Health (EVH)
Evolent Health Inc (EVH)
Evolent Health Stock (NYSE:EVH) Insider Trades
EVH Evolent Health, Inc.
Evolent Health (EVH) Set to Announce Earnings on Thursday
New Strong Buy Stocks for January 5th
BTIG Keeps Their Buy Rating on Evolent Health (EVH)
See More Headlines
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
2/25/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
5,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$41.38
High Stock Price Target
$47.00
Low Stock Price Target
$34.00
Potential Upside/Downside
+21.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$-19,160,000.00
Pretax Margin
-9.19%

Debt

Sales & Book Value

Annual Sales
$1.96 billion
Cash Flow
$1.69 per share
Book Value
$8.60 per share

Miscellaneous

Free Float
111,166,000
Market Cap
$3.92 billion
Optionable
Optionable
Beta
1.49
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Seth Barrie Blackley (Age 45)
    Co-Founder, CEO & Director
    Comp: $1.79M
  • Mr. Dan McCarthy (Age 39)
    CEO of New Century Health & President
    Comp: $1.29M
  • Mr. John Paul JohnsonMr. John Paul Johnson (Age 40)
    Chief Financial Officer
    Comp: $994.22k
  • Mr. Jonathan David Weinberg J.D. (Age 56)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $696.07k
  • Ms. Emily Rafferty (Age 41)
    Chief Operating Officer
  • Mr. Aammaad Shams (Age 40)
    Chief Accounting Officer
    Comp: $341.78k
  • Mr. Robert Cruz
    Chief Technology Officer
  • Mr. Seth R. Frank
    Vice President of Investor Relations
  • Ms. Kali Beyah
    Chief People & Brand Officer
  • Dr. John Tam M.D.
    Chief Strategy Officer














EVH Stock Analysis - Frequently Asked Questions

Should I buy or sell Evolent Health stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares.
View EVH analyst ratings
or view top-rated stocks.

What is Evolent Health's stock price target for 2024?

10 Wall Street research analysts have issued twelve-month price objectives for Evolent Health's stock. Their EVH share price targets range from $34.00 to $47.00. On average, they anticipate the company's stock price to reach $41.38 in the next twelve months. This suggests a possible upside of 21.4% from the stock's current price.
View analysts price targets for EVH
or view top-rated stocks among Wall Street analysts.

How have EVH shares performed in 2024?

Evolent Health's stock was trading at $33.03 at the beginning of the year. Since then, EVH stock has increased by 3.1% and is now trading at $34.07.
View the best growth stocks for 2024 here
.

When is Evolent Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our EVH earnings forecast
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) announced its quarterly earnings data on Wednesday, November, 3rd. The technology company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.05. The technology company earned $222.47 million during the quarter, compared to the consensus estimate of $226.18 million. Evolent Health had a negative net margin of 5.76% and a positive trailing twelve-month return on equity of 6.55%. During the same period in the prior year, the firm posted ($0.07) earnings per share.

What ETFs hold Evolent Health's stock?
What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health issued an update on its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.3 billion.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Evolent Health own?
When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.41%), Granahan Investment Management LLC (2.53%), Point72 Asset Management L.P. (2.33%), Bellevue Group AG (2.07%), Dimensional Fund Advisors LP (1.76%) and Norges Bank (1.15%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends
.

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:EVH) was last updated on 2/25/2024 by MarketBeat.com Staff